In vivo evaluation of CD38 and CD138 as targets for nanoparticle-based drug delivery in multiple myeloma

BACKGROUND: Drug-loaded nanoparticles have established their benefits in the fight against multiple myeloma; however, ligand-targeted nanomedicine has yet to successfully translate to the clinic due to insufficient efficacies reported in preclinical studies. METHODS: In this study, liposomal nanopar...

Descripción completa

Detalles Bibliográficos
Autores principales: Omstead, David T., Mejia, Franklin, Sjoerdsma, Jenna, Kim, Baksun, Shin, Jaeho, Khan, Sabrina, Wu, Junmin, Kiziltepe, Tanyel, Littlepage, Laurie E., Bilgicer, Basar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607744/
https://www.ncbi.nlm.nih.gov/pubmed/33138841
http://dx.doi.org/10.1186/s13045-020-00965-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607744/
https://www.ncbi.nlm.nih.gov/pubmed/33138841
http://dx.doi.org/10.1186/s13045-020-00965-4

Ejemplares similares